RA Capital Management portfolio
150 tracked investments, 92 on the map, $6.7B raised across the mapped portfolio.
- Janux TherapeuticsSeries B
- Arcutis BiotherapeuticsSeries C
- Compass PathwaysPost-IPO Equity
- Mineralys TherapeuticsPost-IPO Equity
- Avalo TherapeuticsPost-IPO Equity
- CG OncologySeries F
- SynthegoSeries E
- Alentis TherapeuticsSeries D
- Stoke TherapeuticsSeries B
- LENZ THERAPEUTICSPost-IPO Equity
- Spyglass PharmaSeries D
- CeribellSeries C
- Superluminal MedicinesSeries A
- Cytek BiosciencesSeries D
- TORL BioTherapeutics
- SynapticureSeries A
- ARS Pharmaceuticals OperationsPost-IPO Debt
- PlexiumSeries B
- Kadmon, a Sanofi CompanyPost-IPO Equity
- Trace NeuroscienceSeries A
- SynthorxSeries C
- Selux DiagnosticsSeries D
- Tenaya TherapeuticsPost-IPO Equity
- CORXEL PharmaceuticalsSeries D
- Ajax TherapeuticsSeries C
- Bambusa TherapeuticsSeries A
- Forge BiologicsSeries B
- VitriVaxSeries B
- CorticaSeries D
- Capstan TherapeuticsSeries B
- RxSightVenture Round
- Pyxis OncologySeries B
- Zura BioPost-IPO Equity
- Vaxess TechnologiesVenture Round
- TassoSeries B
- Everest MedicinesSeries C
- ElektrofiSeries C
- Enara BioSeries B
- Protara TherapeuticsPost-IPO Equity
- Verve TherapeuticsSeries B
- Asher BioSeries C
- Be BiopharmaSeries C
- AmbAgon TherapeuticsSeries A
- Azalea TherapeuticsSeed Round
- AltruBioSeries B
- Xilio TherapeuticsSeries C
- Outpace BioSeries B
- Pluton BiosciencesSeries A
- Avidity BiosciencesPost-IPO Equity
- AM BatteriesSeries B
- NTxSeries B
- Rivus PharmaceuticalsSeries B
- Carmot TherapeuticsSeries E
- Vesta HealthcareSeries C
- Cidara TherapeuticsPost-IPO Equity
- AltimmunePost-IPO Equity
- Apeiron labsSeries A
- Commons ClinicSeries B
- AavantiBioSeries A
- Mariana OncologySeries B
- ArvinasPost-IPO Equity
- Genetix Biotherapeutics Inc.Series D
- Indapta TherapeuticsVenture Round
- Aiolos BioSeries A
- NodexusSeries A
- SurrozenPost-IPO Equity
- Cerebral TherapeuticsSeries C
- BraeburnDebt Financing
- DTx PharmaSeries B
- Bicycle TherapeuticsPost-IPO Equity
- SANUWAVE HealthPost-IPO Equity
- Werewolf TherapeuticsSeries B
- Ovid TherapeuticsPost-IPO Equity
- EquilliumPost-IPO Equity
- MonoparPost-IPO Equity
- CiVi BiopharmaVenture Round
- TeraPore TechnologiesVenture Round
- Medicenna TherapeuticsPost-IPO Equity
- Eledon PharmaceuticalsPost-IPO Equity
- FORMA TherapeuticsSeries D
- Point BiopharmaPost-IPO Equity
- Connect BiopharmaceuticalsSeries C
- ITeos TherapeuticsPost-IPO Equity
- Eidos TherapeuticsSeries B
- Bellicum PharmaceuticalsSeries C
- AthersysVenture Round
- Johnson & Johnson Innovative MedicineSeed Round
- Genelabs TechnologiesVenture Round
- ZS PharmaSeries D
- Covid Apollo ProjectSeed Round
- Intarcia Therapeutics
- Dicerna Pharmaceuticals
Also in the portfolio
- BioAge Labs
- Nimbus Therapeutics
- Triana Biomedicines
- Nautilus Biotechnology
- Terremoto Biosciences
- Aktis Oncology
- Natera
- Acumen Pharmaceuticals
- Design Therapeutics
- Tyra Biosciences
- Halda Therapeutics
- Bristol-Myers Squibb
- TScan Therapeutics
- Stylus Medicine
- Angitia Biopharmaceuticals
- Verdiva Bio
- Exo
- Boundless Bio
- Akari Therapeutics
- Empatica
- NanoMosaic
- Synthekine
- Bia Energy
- Zai Lab
- Edgewise Therapeutics
- ExcepGen
- Sortera Technologies
- Sionna Therapeutics
- Ascendis Pharma
- KalVista Pharmaceuticals
- Abcuro
- Ardelyx
- Prelude Therapeutics
- Adela
- Vivace Therapeutics
- Third Harmonic Bio
- Ventus Therapeutics
- Magenta Medical
- C4 Therapeutics
- Nucleix
- T-knife
- Aurinia Pharmaceuticals
- LianBio
- Iterum Therapeutics
- 89bio
- Sierra Oncology
- Regulus Therapeutics
- Akouos
- Adeo Health Science
- Ra Pharmaceuticals
- Pandion Therapeutics
- Aimmune Therapeutics
- Imara
- Thriveworks
- AmpliPhi Biosciences